Did you suffer severe Pradaxa bleeding or Pradaxa hemorrhaging following radiofrequency ablation to treat atrial fibrillation?
A study published in February 2012 found that patients treated with Pradaxa following atrial fibrillation ablation had higher rates of bleeding and hemorrhaging compared to those treated with warfarin. Pradaxa bleeding side effects, including Pradaxa gastrointestinal hemorrhaging and Pradaxa cerebral bleeding, are often life-threatening, as there is no readily available antidote to reverse serious Pradaxa internal bleeding.
If you were a victim of serious Pradaxa bleeding side effects following atrial fibrillation ablation, you may be entitled to compensation for your pain and suffering. The Pradaxa injury lawyers at Parker Waichman LLP are offering free legal consultations to victims of life-threatening Pradaxa bleeding.
If you or a loved one experienced internal bleeding from Pradaxa after undergoing atrial fibrillation ablation, we urge you to contact our Pradaxa injury lawyers today for a free evaluation of your case.
What is Pradaxa?
Pradaxa is a blood thinner that is approved to prevent the formation of blood clots in people with atrial fibrillation
(irregular heart beat). Touted as a warfarin replacement, it was hoped that people taking Pradaxa would be able to avoid the dietary restrictions and regular blood tests warfarin patients are subjected to. Pradaxa was approved by the U.S. Food & Drug Administration (FDA) in October 2010, but by early 2011, the agency had already received some 500 reports of Pradaxa bleeding injuries. In December 2011, the FDA announced it had launched Pradaxa safety review in response to reports of Pradaxa bleeding injuries and deaths. Unlike warfarin, there is no way to stop a hemorrhage in a patient who experiences bleeding due to Pradaxa. This suggests that even minor events, such as a simple fall, could have fatal consequences for Pradaxa patients.
Pradaxa Bleeding Following Atrial Fibrillation Ablation
In February 2012, a study published in the Journal of the American College of Cardiology suggested that Pradaxa may not be a superior alternative to warfarin in patients who have undergone radiofrequency ablation to treat atrial fibrillation.
The study looked at 290 patients who had undergone the procedure, half of whom were prescribed Pradaxa. The other half received warfarin. Pradaxa was withheld on the day of surgery and restarted 3 hours after ablation; warfarin treatment was uninterrupted.
According to the study, the rate of major bleeding (pericardial tamponade) was 6% with Pradaxa and 1% with warfarin.
The rate of thromboembolic complications was also higher with Pradaxa than with warfarin (2% vs. 0%). The overall bleeding complication rate was 14 percent in the Praxada patients and 6 percent in the warfarin patients.
The study authors determined that Pradaxa may not be appropriate for patients undergoing atrial fibrillation ablation.
They also noted that stopping Pradaxa the morning of the atrial fibrillation ablation procedure might not have been sufficient, since its half-life ranges from 14 to 17 hours.
Legal Help for Pradaxa Bleeding Victims
If you or someone you love suffered a serious Pradaxa bleeding event following atrial fibrillation ablation, you may have valuable legal rights. To discuss your case with one of the Pradaxa injury lawyers at Parker Waichman LLP, please fill out our online form, or call 1-800-YOURLAWYER (1-800-968-7529) today.
More on Eliquis
Daily Aspirin Risks
|Pradaxa Side Effects||Xarelto (Rivaroxaban)||Pradaxa/Atrial Fibrillation||Pradaxa/Hemorrhaging|